Literature DB >> 28712369

A hospital-based matched case-control study to identify risk factors for clinical infection with OXA-48-producing Klebsiella pneumoniae in rectal carriers.

A Madueño1, J Gonzalez Garcia2, A Aguirre-Jaime3, M Lecuona1.   

Abstract

Asymptomatic colonisation of the gastrointestinal tract by carbapenemase-producing Enterobacteriaceae is an important reservoir for transmission, which may precede infection. This retrospective observational case-control study was designed to identify risk factors for developing clinical infection with OXA-48-producing Klebsiella pneumoniae in rectal carriers during hospitalisation. Case patients (n = 76) had carbapenemase-producing K. pneumoniae (CPKP) infection and positive rectal culture for CPKP. Control patients (n = 174) were those with rectal colonisation with CPKP but without CPKP infection. Multivariate analysis identified the presence of a central venous catheter (OR 4·38; 95% CI 2·27-8·42; P = 0·008), the number of transfers between hospital units (OR 1·27; 95% CI (1·06-1·52); P < 0·001) and time at risk (OR 1·02 95% CI 1·01-1·03; P = 0·01) as independent risk factors for CPKP infection in rectal carriers. Awareness of these risk factors may help to identify patients at higher risk of developing CPKP infection.

Entities:  

Keywords:  Antibiotic resistance; Klebsiella; hospital-acquired (nosocomial) infections

Mesh:

Substances:

Year:  2017        PMID: 28712369      PMCID: PMC9148781          DOI: 10.1017/S095026881700142X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  10 in total

1.  Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant.

Authors:  Christopher J Gregory; Eloisa Llata; Nicholas Stine; Carolyn Gould; Luis Manuel Santiago; Guillermo J Vazquez; Iraida E Robledo; Arjun Srinivasan; Richard V Goering; Kay M Tomashek
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

2.  Association between hospital-acquired infections and patients' transfers.

Authors:  M Eveillard; J L Quenon; P Rufat; A Mangeol; F Fauvelle
Journal:  Infect Control Hosp Epidemiol       Date:  2001-11       Impact factor: 3.254

Review 3.  Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review.

Authors:  C E French; C Coope; L Conway; J P T Higgins; J McCulloch; G Okoli; B C Patel; I Oliver
Journal:  J Hosp Infect       Date:  2016-10-14       Impact factor: 3.926

4.  Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.

Authors:  Abraham Borer; Lisa Saidel-Odes; Seada Eskira; Ronit Nativ; Klaris Riesenberg; Ilana Livshiz-Riven; Francisc Schlaeffer; Michael Sherf; Nejama Peled
Journal:  Am J Infect Control       Date:  2011-09-09       Impact factor: 2.918

5.  Lessons from an outbreak of metallo-β-lactamase-producing Klebsiella oxytoca in an intensive care unit: the importance of time at risk and combination therapy.

Authors:  S Vergara-López; M C Domínguez; M C Conejo; Á Pascual; J Rodríguez-Baño
Journal:  J Hosp Infect       Date:  2014-01-15       Impact factor: 3.926

Review 6.  Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.

Authors:  José Ramón Paño Pardo; Sergio Serrano Villar; Juan Carlos Ramos Ramos; Vicente Pintado
Journal:  Enferm Infecc Microbiol Clin       Date:  2014-12       Impact factor: 1.731

Review 7.  ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients.

Authors:  E Tacconelli; M A Cataldo; S J Dancer; G De Angelis; M Falcone; U Frank; G Kahlmeter; A Pan; N Petrosillo; J Rodríguez-Baño; N Singh; M Venditti; D S Yokoe; B Cookson
Journal:  Clin Microbiol Infect       Date:  2014-01       Impact factor: 8.067

Review 8.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak.

Authors:  José Ramón Paño-Pardo; Guillermo Ruiz-Carrascoso; Carolina Navarro-San Francisco; Rosa Gómez-Gil; Marta Mora-Rillo; María Pilar Romero-Gómez; Natalia Fernández-Romero; Julio García-Rodríguez; Verónica Pérez-Blanco; Francisco Moreno-Ramos; Jesús Mingorance
Journal:  J Antimicrob Chemother       Date:  2012-10-07       Impact factor: 5.790

10.  A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection.

Authors:  Luci Correa; Marines Dalla Valle Martino; Itacy Siqueira; Jacyr Pasternak; Ana Cristina Gales; Claudia Vallone Silva; Thiago Zinsly Sampaio Camargo; Patricia Faria Scherer; Alexandre Rodrigues Marra
Journal:  BMC Infect Dis       Date:  2013-02-11       Impact factor: 3.090

  10 in total
  1 in total

Review 1.  Treatment of Infections by OXA-48-Producing Enterobacteriaceae.

Authors:  Adam Stewart; Patrick Harris; Andrew Henderson; David Paterson
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.